Further, ERS suppressed the expression of B-cell lymphoma 2 (Bcl-2) via introduction of CHOP and led to the activation of Bcl-2 associated protein X (BAX) through activation of JNK, which contributed to ERS-induced apoptosis in BM-MSCs from SLE patients. The gene discussed is BCL2; the disease is systemic lupus erythematosus.